Luteinizing hormone signaling and breast cancer: Polymorphisms and age of onset

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 4, 2003, Pages 1653-1657

  Powell, B L ^a,b   Piersma, D ^b   Kevenaar, M E ^b   Van Staveren, I L ^b   Themmen, A P N ^b   Iacopetta, B J ^a   Berns, Els M J J ^b,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DNA; ESTROGEN; ESTROGEN RECEPTOR; FOLLITROPIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGE FACTORS; ALLELES; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; LUTEINIZING HORMONE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; RECEPTORS, LH; SIGNAL TRANSDUCTION;

EID: 0038021577     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021585     Document Type: Article

References (24)

1. Harris JR, Lippman ME, Veronesi U, Willett W 1992 Breast cancer. N Engl J Med 327:319-328, 390-398, 473-480
2. Martin AM, Weber BL 2000 Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 92:1126-1135
3. Kristensen VN, Borresen-Dale AL 2000 Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism. Murat Res 462:323-333
4. Bharaj B, Scorilas A, Giai R, Diamandis EP 2000 TA repeat polymorphism of the 5-alpha-reductase gene and breast cancer. Cancer Epidemiol Biomarkers Prev 9:387-393
5. Themmen APN, Huhtaniemi IT 2000 Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21:551-583
6. Nilsson C, Jiang M, Pettersson K, Iitia A, Makela M, Simonsen H, Easteal S, Herrera RJ, Huhtaniemi IT 1998 Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clin Endocrinol (Oxf) 49:369-376
7. Haavisto AM, Pettersson K, Bergendahl M, Virkamaki A, Huhtaniemi IT 1995 Occurrence and biological properties of a common genetic variant of luteinizing hormone. J Clin Endocrinol Metab 80:1257-1263
8. Richter-Unruh A, Martens JWM, Verhoef-Post M, Wessels K, Kors WA, Sinnecker GHG, Boehmer A, Drop, SLS, Toledo SPA, Brunner HG, Themmen APN 2002 Leydig cell hypoplasia: cases with new mutations, new polymorphism and cases without mutations in the luteinizing hormone receptor gene. Clin Endocrinol (Oxf) 56:103-112
9. Atger M, Mishrahi M, Sar S, Le Flem A, Dersen P, Milgrom E 1995 Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promotor and 5′ non-coding regions. Mol Cell Endocrinol 111:113-123
10. Rodien P, Cetani F, Costagliola S, Tonacchera M, Duprez L, Minegishi T, Govearts C, Vassart G 1998 Evidence for an allelic variant of the human LC/CG receptor rather than a gene duplication: functional comparison of wild-type and variant receptors. J Clin Endocrinol Metab 83:4431-4434
11. Wu SM, Hallermeier KM, Brain C, Berry AC, Grant DB, Griffin JE, Wilson JD, Cutler Jr GB, Chanm WY 1998 Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol Endocrinol 12:1651-1660
12. Nilsson C, Pettersson K, Millar RP, Coerver KA, Matzuk MM, Huhtaniemi IT 1997 Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group. Fertil Steril 67:998-1004
13. Key TJ, Verkasalo PK, Banks E 2001 Epidemiology of breast cancer. Lancet Oncol 2:133-140
14. Soong R, Iacopetta BJ, Harvey JM, Sterrett GF, Dawkins HJ, Hahnel R, Robbins PD 1997 Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer. Int J Cancer 74:642-647
15. Furui K, Suganuma N, Tsukahara S, Asada Y, Kikkawa F, Tanaka M, Ozawa T, Tomoda Y 1994 Identification of two point mutations in the gene coding luteinizing hormone (LH) beta-subunit, associated with immunologically anomalous LH variants. J Clin Endocrinol Metab 78:107-113
16. Kroman N, Jensen M-B, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M 2000 Factors influencing the effect of age on prognosis in breast cancer: population based study. Br Med J 320:474-478
17. Lubin JH, Burns PE, Blot WJ, Lees AW, May C, Morris LE, Fraumeni Jr JF 1982 Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis J Natl Cancer Inst 68:211-217
18. Cold S, Hansen S, Overvad K, Rose C 1998 A woman's build and the risk of breast cancer. Eur J Cancer 34:1163-1174
19. Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Pettersson K, Huhtaniemi IT 2000 Genetic variant of luteinizing hormone and risk of breast cancer in older women. Cancer Epidemiol Biomarkers Prev 9:839-842
20. Cramer DW, Petterson KS, Barbieri RL, Huhtaniemi IT 2000 Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone. Hum Reprod 15:2103-2107
21. Meduri G, Chamaux N, Loosfelt H, Jolivet A, Spyratos F, Brailly S, Milgrom EE 1997 Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res 57:857-864
22. Milliken EL, Ameduri RK, Landis MD, Behrooz A, Abdul-Karim FW, Keri RA 2002 Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinology 143:3671-3680
23. Tanaka Y, Kuwabara K, Okazaki T, Fujita T, Oizumi I, Kaiho SI, Ogata E 2000 Gonadotropins stimulate growth of MCF-7 human breast cells by promoting intracellular conversion of adrenal androgens to estrogens. Oncology 59:19-23
24. Toledo SPA, Brunner HG, Kraaij R, Post M, Dahia PL, Hayashida CY, Kremer H, Themmen APN 1996 An inactivating mutation in the luteinizing hormone receptor causes amenorrhea in a 46, XX female. J Clin Endocrinol Metab 81:3850-3854